{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T05:55:55Z","timestamp":1747202155968,"version":"3.40.5"},"reference-count":0,"publisher":"RCVS Knowledge","issue":"4","license":[{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["VE"],"abstract":"<jats:p>PICO question\r\nIn cats with chronic bronchospasm and airway hypersensitivity (asthma) do oral glucocorticoids or inhaled glucocorticoids more effectively control the clinical signs?\r\n\u00a0\r\nClinical bottom line\r\nCategory of research question\r\nTreatment\r\nThe number and type of study designs reviewed\r\nThree prospective randomised clinical trials were appraised. Two of the studies followed a crossover design and had a control group, whilst the third study described an interrupted time series\r\nStrength of evidence\r\nWeak\r\nOutcomes reported\r\nThe available studies deemed a reduction in eosinophilia on bronchoalveolar lavage fluid analysis, and a reduction in airway resistance as markers of treatment efficacy\r\nConclusion\r\nThere is weak evidence to suggest equal treatment efficacy of oral and inhaled glucocorticoid therapy for management of feline asthma. Higher powered studies would be required before a definitive recommendation can be made\r\n\u00a0\r\nHow to apply this evidence in practice\r\nThe application of evidence into practice should take into account multiple factors, not limited to: individual clinical expertise, patient\u2019s circumstances and owners\u2019 values, country, location or clinic where you work, the individual case in front of you, the availability of therapies and resources.\r\nKnowledge Summaries are a resource to help reinforce or inform decision making. They do not override the responsibility or judgement of the practitioner to do what is best for the animal in their care.<\/jats:p>","DOI":"10.18849\/ve.v7i4.560","type":"journal-article","created":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T10:14:01Z","timestamp":1670408041000},"source":"Crossref","is-referenced-by-count":0,"title":["Do inhaled or oral glucocorticoids more effectively control feline asthma?"],"prefix":"10.18849","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8341-9074","authenticated-orcid":false,"given":"Savannah","family":"Williams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8083","published-online":{"date-parts":[[2022,12,7]]},"container-title":["Veterinary Evidence"],"original-title":[],"link":[{"URL":"https:\/\/veterinaryevidence.org\/index.php\/ve\/article\/download\/560\/784","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/veterinaryevidence.org\/index.php\/ve\/article\/download\/560\/784","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T10:14:02Z","timestamp":1670408042000},"score":1,"resource":{"primary":{"URL":"https:\/\/veterinaryevidence.org\/index.php\/ve\/article\/view\/560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,7]]},"references-count":0,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,11,2]]}},"URL":"https:\/\/doi.org\/10.18849\/ve.v7i4.560","relation":{},"ISSN":["2396-9776"],"issn-type":[{"type":"electronic","value":"2396-9776"}],"subject":[],"published":{"date-parts":[[2022,12,7]]}}}